This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the AANS and AANS/CNS Section on Disorders of the Spine and Peripheral Nerves. The AANS is accredited by the ACCME to provide continuing medical education for physicians.
The AANS designates this live activity for a maximum of 24 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Before the program, anyone in control of the educational content of this activity will disclose the existence of any financial interest and/or the relationship they have with the manufacturer(s) of any commercial product(s). Disclosures will be included in the meeting app.
AANS would like to thank Stryker, DePuy, Olympus, Joimax, Accelus, Arthrex, Spineology, Elliquence, and RIWO for an educational grant to support the 2024 SPINE SUMMIT.
This CME activity is supported by in-kind donations from Stryker, DePuy, Joimax, Accelus, Arthrex, Spineology, Elliquence, and RIWO.
The material presented at the 2024 Spine Summit has been made available by the AANS/CNS Section on Disorders of the Spine and Peripheral Nerves and the AANS for educational purposes only. The material is not intended to represent the only, nor necessarily the best, method or procedure appropriate for the medical situations discussed, but rather it is intended to present an approach, view, statement, or opinion of the faculty, which may be helpful to others who face similar situations. Neither the content (whether written or oral) of any course, seminar, or other presentation in the program, nor the use of a specific product in conjunction therewith, nor the exhibition of any materials by any parties coincident with the program, should be construed as indicating endorsement or approval of the views presented, the products used, or the materials exhibited by the (insert meeting organization) and jointly provided by the AANS, or its Committees, Commissions, or Affiliates.
Neither the content (whether written or oral) of any course, seminar or other presentation in the program, nor the use of a specific product in conjunction therewith, nor the exhibition of any materials by any parties coincident with the program, should be construed as indicating endorsement or approval of the views presented, the products used, or the materials exhibited by the AANS/CSN Section on Disorders of the Spine and Peripheral Nerves and jointly provided by the AANS, or its Committees, Commissions, or Affiliates.
Neither the AANS nor the AANS/CNS Section on Disorders of the Spine and Peripheral Nerves makes any statements, representations or warranties (whether written or oral) regarding the Food and Drug Administration (FDA) status of any product used or referred to in conjunction with any course, seminar or other presentation being made available as part of 2024 Spine Summit. Faculty members shall have sole responsibility to inform attendees of the FDA status of each product that is used in conjunction with any course, seminar, or presentation and whether such use of the product is in compliance with FDA regulations.
AANS/CNS Section on Disorders of the Spine and Peripheral Nerves
Contact Us: [email protected]